Physician profile
John Pham
NPI 1982144697
$696.84
in general payments reported to CMS, 2019-2025
13 companies · $299 in 2025
The $299 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.18 · 2021: $171 · 2022: $28.24 · 2023: $39.87 · 2024: $85.18 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $167.66 | 2019-2025 | Doc Band |
| Welch Allyn | $145.66 | 2021 | |
| Seqirus USA INC | $81.88 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Sanofi-Aventis U.S. LLC | $57.56 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $45.18 | 2025 | Gardasil 9, Enflonsia, Vaxneuvance |
| Abbott Laboratories | $39.47 | 2025 | Id Now Instrument |
| Sanofi Pasteur INC. | $33.20 | 2022-2023 | |
| Genzyme Corporation | $25.05 | 2024 | |
| Seagen INC. | $25.00 | 2021 | |
| Organon LLC | $23.43 | 2025 | Vtama |
| Sobi, INC | $20.34 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.81 | 2025 | Zoryve |
| Mission Pharmacal Company | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.